Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
This explains the function of the index divisor for investors, including how it influences observed returns and analysis.
26,233 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A voluntary recall of thousands of Waymo AVs grabbed headlines, but the bigger story is the decade ahead for autonomo...
Earnings season is winding down, but the real story is what company leaders say about the road ahead. This guide help...
Investors are buzzing as SAIC reports stronger-than-expected results and a growing federal pipeline. This article bre...
AMD is pursuing a bold AI strategy that could drive material growth in data-center compute. This article breaks down ...
Vanguard's dividend-growth ETF outpaced the Dividend Aristocrats ETF over the past decade, delivering higher returns ...
The memory market has reshaped profits for chip makers and device companies. This article explains how Micron benefit...
Carnival stock moved sharply this week after a mixed update. Here are three burning questions investors should consid...
Tech-focused investors watched TeraWulf surge after a major AI data-center lease deal, signaling potential recurring ...
Apple filed a federal lawsuit alleging trade secret theft by former employees at OpenAI, threatening hardware know-ho...
Three dividend ETFs stand out as 2026 nears: SCHD for cost and broad exposure, HDV for quality screening, and DGRO fo...
When a prominent investor trims a large stake, the market often swings. This piece breaks down what happened with Aca...